tiprankstipranks
Eli Lilly & Co (DE:LLY)
XETRA:LLY

Compare Eli Lilly & Co (LLY) vs. Competitors

195 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Eli Lilly & Co
€796.30
€772.25B
36.36
19.64%
17 Buy
2 Hold
1 Sell
Strong Buy
Johnson & Johnson
$238.41
$581.20B
18.81
60.87%
11 Buy
6 Hold
0 Sell
Moderate Buy
Merck & Company
$123.18
$294.91B
14.46
56.02%
12 Buy
7 Hold
0 Sell
Moderate Buy
Novartis
$154.42
$279.53B
19.02
51.45%
3 Buy
3 Hold
0 Sell
Moderate Buy
AbbVie
$211.59
$374.13B
96.82
20.45%
15 Buy
7 Hold
0 Sell
Moderate Buy
AstraZeneca
15216.00 p
£235.97B
28.13
46.67%
13 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:LLY
Eli Lilly & Co
818.80
194.36
31.13%
JNJ
Johnson & Johnson
241.30
94.42
64.29%
MRK
Merck & Company
123.18
44.14
55.85%
NVS
Novartis
154.42
52.56
51.61%
ABBV
AbbVie
211.59
37.59
21.60%
GB:AZN
AstraZeneca
15,216.00
5,714.60
60.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts